Monthly
US$200
Billed every month
Sign in to subscribeAs of 13 November 2026, for Potassium Chloride Granules, 4 applications are listed as under review at China's CDE; 3 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 38 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 2 applicationsAccepted: 2 applications
Current coverage may be incomplete
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 38 holders; 3 in the quality-and-efficacy consistency-evaluation category, and 34 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20264543 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20264542 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20264259 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20264258 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuo Zhou Dong Le Pharmaceutical Co., Ltd. romanized | Zhuo Zhou Dong Le Pharmaceutical Co., Ltd. romanized | 国药准字H20263837 | 2026/04/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuo Zhou Dong Le Pharmaceutical Co., Ltd. romanized | Zhuo Zhou Dong Le Pharmaceutical Co., Ltd. romanized | 国药准字H20263836 | 2026/04/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | 国药准字H20263088 | 2026/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20256201 | 2025/12/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20256165 | 2025/12/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Tian Xing Hui Pharmaceuticals Technology Co., Ltd. romanized | Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20255992 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20255728 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Tong De Pharma Co., Ltd. romanized | Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Sen Rong Pharmaceuticals Technology Co., Ltd. romanized | Jin Hong Pharma Co., Ltd. romanized | 国药准字H20255536 | 2025/09/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Sen Rong Pharmaceuticals Technology Co., Ltd. romanized | Jin Hong Pharma Co., Ltd. romanized | 国药准字H20255537 | 2025/09/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang Kang Li Pharma Co., Ltd. romanized | Shijiazhuang Kang Li Pharma Co., Ltd. romanized | 国药准字H20255001 | 2025/07/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang Kang Li Pharma Co., Ltd. romanized | Shijiazhuang Kang Li Pharma Co., Ltd. romanized | 国药准字H20255000 | 2025/07/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | 国药准字H20254802 | 2025/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | 国药准字H20254801 | 2025/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Jia He Pharma Co., Ltd. romanized | Anhui Jia He Pharma Co., Ltd. romanized | 国药准字H20254770 | 2025/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254610 | 2025/06/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254609 | 2025/06/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei San He Shi Chuang Bio Technology Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20254500 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei San He Shi Chuang Bio Technology Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20254499 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chi Feng Gu De Pharma Co., Ltd. romanized | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20254413 | 2025/06/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Xin He Bio Technology Co., Ltd. romanized | Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254412 | 2025/06/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254319 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fuzhou Ji Shi Pharmaceuticals Technology Co., Ltd. romanized | Fuzhou Ji Shi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254185 | 2025/05/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fuzhou Ji Shi Pharmaceuticals Technology Co., Ltd. romanized | Fuzhou Ji Shi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254186 | 2025/05/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guizhou Rui He Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20253850 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guizhou Rui He Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20253851 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ji Chuan Pharma Group Co., Ltd. romanized | Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20253821 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ji Chuan Pharma Group Co., Ltd. romanized | Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20253820 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Pu De Pharma Co., Ltd. romanized | Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20249672 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | Kang Zhi Pharma Co., Ltd. romanized | 国药准字H20247296 | 2024/11/28 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20249381 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20244641 | 2024/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20244642 | 2024/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | HAINAN HUALON PHARMACEUTICAL CO.,LTD | 国药准字H20244649 | 2024/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | HAINAN HUALON PHARMACEUTICAL CO.,LTD | 国药准字H20244648 | 2024/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | Kang Zhi Pharma Co., Ltd. romanized | 国药准字H33020123 | 2024/08/01 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244501 | 2024/07/30 | See source | Not stated by source | CDE |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244502 | 2024/07/30 | See source | Not stated by source | CDE |
| Zhejiang Tong Wu Biopharmaceuticals Co., Ltd. romanized | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20244463 | 2024/07/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | 2024/07/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20244070 | 2024/06/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20244069 | 2024/06/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | 2024/04/30 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | 2024/04/30 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Beijing Bai Ya Joint Drug Research Institute Co., Ltd. romanized | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20243491 | 2024/04/11 | 1.5g | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243235 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243234 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20243143 | 2024/02/06 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20223630 | 2022/08/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20223629 | 2022/08/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | YaoPharma Co., Ltd. | 国药准字H50020684 | 2018/11/19 | 1.0g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | YaoPharma Co., Ltd. | 国药准字H50020683 | 2018/11/19 | 1.5g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Nanjing Hai Jing Pharma Co., Ltd. romanized | Nanjing Hai Jing Pharma Co., Ltd. romanized | 国药准字H20254945 | 2025/07/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20254314 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 50 distinct approval numbers and 33 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010100299 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H50020684 | See source | Category A | XA12BAL208N001010101066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244642 | See source | Category A | XA12BAL208N001010101453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010101966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010102068 | NHSA |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254610 | See source | Category A | XA12BAL208N001010102617 | NHSA |
| Shijiazhuang Kang Li Pharma Co., Ltd. romanized | 国药准字H20255000 | See source | Category A | XA12BAL208N001010102741 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20254319 | See source | Category A | XA12BAL208N001010102763 | NHSA |
| Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | 国药准字H20254801 | See source | Category A | XA12BAL208N001010102892 | NHSA |
| Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20249672 | See source | Category A | XA12BAL208N001010102918 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20249381 | See source | Category A | XA12BAL208N001010104383 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001010104506 | NHSA |
| Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | 国药准字H20263088 | See source | Category A | XA12BAL208N001010106673 | NHSA |
| Guizhou Rui He Pharmaceutical Co., Ltd. romanized | 国药准字H20253851 | See source | Category A | XA12BAL208N001010110247 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223629 | See source | Category A | XA12BAL208N001010110307 | NHSA |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20254314 | See source | Category A | XA12BAL208N001010180537 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244501 | See source | Category A | XA12BAL208N001010182209 | NHSA |
| Hainan Hai He Pharmaceutical Co., Ltd. romanized | 国药准字H20243491 | See source | Category A | XA12BAL208N001010183184 | NHSA |
| Hebei San He Shi Chuang Bio Technology Co., Ltd. romanized | 国药准字H20254500 | See source | Category A | XA12BAL208N001010183409 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20243143 | See source | Category A | XA12BAL208N001010184206 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244069 | See source | Category A | XA12BAL208N001010184209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254666 | See source | Category A | XA12BAL208N001010184220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244648 | See source | Category A | XA12BAL208N001010184221 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247296 | See source | Category A | XA12BAL208N001010184245 | NHSA |
| Name not romanized | 国药准字H20243235 | See source | Category A | XA12BAL208N001010184294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254186 | See source | Category A | XA12BAL208N001010184338 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20256165 | See source | Category A | XA12BAL208N001010184621 | NHSA |
| Zhejiang Tong Wu Biopharmaceuticals Co., Ltd. romanized | 国药准字H20244463 | See source | Category A | XA12BAL208N001010184712 | NHSA |
| Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized | 国药准字H20264542 | See source | Category A | XA12BAL208N001010184724 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254413 | See source | Category A | XA12BAL208N001010184867 | NHSA |
| Sichuan Tian Xing Hui Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255992 | See source | Category A | XA12BAL208N001010185049 | NHSA |
| Anhui Jia He Pharma Co., Ltd. romanized | 国药准字H20254770 | See source | Category A | XA12BAL208N001010185179 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010200299 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H50020684 | See source | Category A | XA12BAL208N001010201066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244642 | See source | Category A | XA12BAL208N001010201453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010201966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010202068 | NHSA |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254610 | See source | Category A | XA12BAL208N001010202617 | NHSA |
| Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20249672 | See source | Category A | XA12BAL208N001010202918 | NHSA |
| Guizhou Rui He Pharmaceutical Co., Ltd. romanized | 国药准字H20253851 | See source | Category A | XA12BAL208N001010210247 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223630 | See source | Category A | XA12BAL208N001010210307 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244501 | See source | Category A | XA12BAL208N001010282209 | NHSA |
| Hainan Hai He Pharmaceutical Co., Ltd. romanized | 国药准字H20243491 | See source | Category A | XA12BAL208N001010283184 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20243143 | See source | Category A | XA12BAL208N001010284206 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244069 | See source | Category A | XA12BAL208N001010284209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254666 | See source | Category A | XA12BAL208N001010284220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244648 | See source | Category A | XA12BAL208N001010284221 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247296 | See source | Category A | XA12BAL208N001010284245 | NHSA |
| Name not romanized | 国药准字H20243235 | See source | Category A | XA12BAL208N001010284294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254186 | See source | Category A | XA12BAL208N001010284338 | NHSA |
| Zhejiang Tong Wu Biopharmaceuticals Co., Ltd. romanized | 国药准字H20244463 | See source | Category A | XA12BAL208N001010284712 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254413 | See source | Category A | XA12BAL208N001010284867 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010300299 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H50020684 | See source | Category A | XA12BAL208N001010301066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244642 | See source | Category A | XA12BAL208N001010301453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010301966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010302068 | NHSA |
| Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20249672 | See source | Category A | XA12BAL208N001010302918 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223629 | See source | Category A | XA12BAL208N001010310307 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244501 | See source | Category A | XA12BAL208N001010382209 | NHSA |
| Hainan Hai He Pharmaceutical Co., Ltd. romanized | 国药准字H20243491 | See source | Category A | XA12BAL208N001010383184 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20243143 | See source | Category A | XA12BAL208N001010384206 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244069 | See source | Category A | XA12BAL208N001010384209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254666 | See source | Category A | XA12BAL208N001010384220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244648 | See source | Category A | XA12BAL208N001010384221 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247296 | See source | Category A | XA12BAL208N001010384245 | NHSA |
| Name not romanized | 国药准字H20243235 | See source | Category A | XA12BAL208N001010384294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254186 | See source | Category A | XA12BAL208N001010384338 | NHSA |
| Zhejiang Tong Wu Biopharmaceuticals Co., Ltd. romanized | 国药准字H20244463 | See source | Category A | XA12BAL208N001010384712 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254413 | See source | Category A | XA12BAL208N001010384867 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010400299 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H50020684 | See source | Category A | XA12BAL208N001010401066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244642 | See source | Category A | XA12BAL208N001010401453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010401966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010402068 | NHSA |
| Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20249672 | See source | Category A | XA12BAL208N001010402918 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223630 | See source | Category A | XA12BAL208N001010410307 | NHSA |
| Hainan Hai He Pharmaceutical Co., Ltd. romanized | 国药准字H20243491 | See source | Category A | XA12BAL208N001010483184 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20243143 | See source | Category A | XA12BAL208N001010484206 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244069 | See source | Category A | XA12BAL208N001010484209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254666 | See source | Category A | XA12BAL208N001010484220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244648 | See source | Category A | XA12BAL208N001010484221 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247296 | See source | Category A | XA12BAL208N001010484245 | NHSA |
| Name not romanized | 国药准字H20243235 | See source | Category A | XA12BAL208N001010484294 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254413 | See source | Category A | XA12BAL208N001010484867 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010500299 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244642 | See source | Category A | XA12BAL208N001010501453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010501966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010502068 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223629 | See source | Category A | XA12BAL208N001010510307 | NHSA |
| Hainan Hai He Pharmaceutical Co., Ltd. romanized | 国药准字H20243491 | See source | Category A | XA12BAL208N001010583184 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20243143 | See source | Category A | XA12BAL208N001010584206 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247296 | See source | Category A | XA12BAL208N001010584245 | NHSA |
| Name not romanized | 国药准字H20243235 | See source | Category A | XA12BAL208N001010584294 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254413 | See source | Category A | XA12BAL208N001010584867 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010600299 | NHSA |
| Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized | 国药准字H20253820 | See source | Category A | XA12BAL208N001010601453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010601966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010602068 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223630 | See source | Category A | XA12BAL208N001010610307 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010700299 | NHSA |
| Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized | 国药准字H20253820 | See source | Category A | XA12BAL208N001010701453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010701966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010702068 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223629 | See source | Category A | XA12BAL208N001010710307 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010800299 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H42022296 | See source | Category A | XA12BAL208N001010801966 | NHSA |
| Chengdu Tong De Pharma Co., Ltd. romanized | 国药准字H20255731 | See source | Category A | XA12BAL208N001010802068 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223630 | See source | Category A | XA12BAL208N001010810307 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001010900299 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223629 | See source | Category A | XA12BAL208N001010910307 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20244464 | See source | Category A | XA12BAL208N001011000299 | NHSA |
| Hua Nuo Pharmaceuticals (Guangzhou) Co., Ltd. romanized | 国药准字H20223630 | See source | Category A | XA12BAL208N001011010307 | NHSA |
| Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized | 国药准字H50020683 | See source | Category A | XA12BAL208N001020101066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244641 | See source | Category A | XA12BAL208N001020101453 | NHSA |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254609 | See source | Category A | XA12BAL208N001020102617 | NHSA |
| Shijiazhuang Kang Li Pharma Co., Ltd. romanized | 国药准字H20255001 | See source | Category A | XA12BAL208N001020102741 | NHSA |
| Shanxi Huang Cheng Xiang Fu Pharma Co., Ltd. romanized | 国药准字H20254802 | See source | Category A | XA12BAL208N001020102892 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001020104506 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244502 | See source | Category A | XA12BAL208N001020182209 | NHSA |
| Hebei San He Shi Chuang Bio Technology Co., Ltd. romanized | 国药准字H20254499 | See source | Category A | XA12BAL208N001020183409 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244070 | See source | Category A | XA12BAL208N001020184209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254667 | See source | Category A | XA12BAL208N001020184220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244649 | See source | Category A | XA12BAL208N001020184221 | NHSA |
| Name not romanized | 国药准字H20243234 | See source | Category A | XA12BAL208N001020184294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254185 | See source | Category A | XA12BAL208N001020184338 | NHSA |
| Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized | 国药准字H20264543 | See source | Category A | XA12BAL208N001020184724 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254414 | See source | Category A | XA12BAL208N001020184867 | NHSA |
| Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized | 国药准字H50020683 | See source | Category A | XA12BAL208N001020201066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244641 | See source | Category A | XA12BAL208N001020201453 | NHSA |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | 国药准字H20254609 | See source | Category A | XA12BAL208N001020202617 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001020204506 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244502 | See source | Category A | XA12BAL208N001020282209 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244070 | See source | Category A | XA12BAL208N001020284209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254667 | See source | Category A | XA12BAL208N001020284220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244649 | See source | Category A | XA12BAL208N001020284221 | NHSA |
| Name not romanized | 国药准字H20243234 | See source | Category A | XA12BAL208N001020284294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254185 | See source | Category A | XA12BAL208N001020284338 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254414 | See source | Category A | XA12BAL208N001020284867 | NHSA |
| Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized | 国药准字H50020683 | See source | Category A | XA12BAL208N001020301066 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244641 | See source | Category A | XA12BAL208N001020301453 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001020304506 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20244502 | See source | Category A | XA12BAL208N001020382209 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244070 | See source | Category A | XA12BAL208N001020384209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254667 | See source | Category A | XA12BAL208N001020384220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244649 | See source | Category A | XA12BAL208N001020384221 | NHSA |
| Name not romanized | 国药准字H20243234 | See source | Category A | XA12BAL208N001020384294 | NHSA |
| Heng Yan Biopharmaceuticals Technology (Xiamen) Co., Ltd. romanized | 国药准字H20254185 | See source | Category A | XA12BAL208N001020384338 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254414 | See source | Category A | XA12BAL208N001020384867 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244641 | See source | Category A | XA12BAL208N001020401453 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001020404506 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20244070 | See source | Category A | XA12BAL208N001020484209 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254667 | See source | Category A | XA12BAL208N001020484220 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244649 | See source | Category A | XA12BAL208N001020484221 | NHSA |
| Name not romanized | 国药准字H20243234 | See source | Category A | XA12BAL208N001020484294 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254414 | See source | Category A | XA12BAL208N001020484867 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20244641 | See source | Category A | XA12BAL208N001020501453 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001020504506 | NHSA |
| Chi Feng Gu De Pharma Co., Ltd. romanized | 国药准字H20254414 | See source | Category A | XA12BAL208N001020584867 | NHSA |
| Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized | 国药准字H20253821 | See source | Category A | XA12BAL208N001020601453 | NHSA |
| Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized | 国药准字H20253821 | See source | Category A | XA12BAL208N001020701453 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001020801966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001020901966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021001966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021101966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021201966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021301966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021401966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021501966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021601966 | NHSA |
| Wuhan Tai Fu Pharmaceutical Co., Ltd. romanized | 国药准字H20247090 | See source | Category A | XA12BAL208N001021701966 | NHSA |
| Hainan Ye Hui Yuan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H33020123 | See source | Category A | XA12BAL208N001030104506 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 4 filings and 4 distinct first applicants.
Generic 4
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Chongqing Xi Er An Pharma Co., Ltd. romanized; Chongqing Guo Tai Kang Ning Pharmaceutical Co., Ltd. romanized | CYHS2602172 | Generic | 2026/09/01 | Not stated by source | CDE |
| Zi Bo Wan Jie Pharmaceutical Co., Ltd. romanized | CYHS2600797 | Generic | 2026/04/08 | Not stated by source | CDE |
| Shijiazhuang Kai Sai Pharmaceuticals Technology Co., Ltd. romanized; Hua Xia Guo Yao (He Ze) Pharmaceutical Co., Ltd. romanized | CYHS2600553 | Generic | 2026/02/27 | Not stated by source | CDE |
| Fujian Rui Tai Lai Pharmaceuticals Technology Co., Ltd. romanized; Anhui Jia He Pharma Co., Ltd. romanized | CYHS2503852 | Generic | 2025/11/01 | Not stated by source | CDE |
Loaded records: 3 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Chongqing Xi Er An Pharma Co., Ltd. romanized; Chongqing Guo Tai Kang Ning Pharmaceutical Co., Ltd. romanized | CYHS2602172 | Generic | 2026/09/01 | Not stated by source | CDE |
| Zi Bo Wan Jie Pharmaceutical Co., Ltd. romanized | CYHS2600797 | Generic | 2026/04/08 | Not stated by source | CDE |
| Shijiazhuang Kai Sai Pharmaceuticals Technology Co., Ltd. romanized; Hua Xia Guo Yao (He Ze) Pharmaceutical Co., Ltd. romanized | CYHS2600553 | Generic | 2026/02/27 | Not stated by source | CDE |
Non-component matches: 13 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 氯化钾 · No verified English name | Hunan Hao Sen Pharmaceutical Co., Ltd. romanized | Y20260000475 | I | Exact ingredient | 2026/06/09 | CDE |
| 氯化钾 · No verified English name | Hunan Xin Lv Fang Pharma Co., Ltd. romanized | Y20240001312 | I | Exact ingredient | 2025/02/07 | CDE |
| 氯化钾 · No verified English name | Henan Pu Rui Pharmaceutical Co., Ltd. romanized | Y20200001526 | A | Exact ingredient | 2026/01/01 | CDE |
| 氯化钾 · No verified English name | Chemtrade Solutions LLC | Y20210000064 | I | Exact ingredient | 2021/02/03 | CDE |
| 氯化钾 · No verified English name | K+S Minerals and Agriculture GmbH | Y20200001313 | A | Exact ingredient | 2023/02/22 | CDE |
| 氯化钾 · No verified English name | Tianjin Hai Guang Technology Development Co., Ltd. romanized | Y20190009650 | A | Exact ingredient | 2025/05/14 | CDE |
| 氯化钾 · No verified English name | Jiangsu Sheng Qin Fen Pharma Co., Ltd. romanized | Y20190009523 | A | Exact ingredient | 2025/05/24 | CDE |
| 氯化钾 · No verified English name | Zi Gong Hong He Pharmaceutical Co., Ltd. romanized | Y20190009377 | A | Exact ingredient | 2025/03/29 | CDE |
| 氯化钾 · No verified English name | Hebei Hua Chen Pharma Group Co., Ltd. romanized | Y20190008767 | A | Exact ingredient | 2025/08/16 | CDE |
| 氯化钾 · No verified English name | Tai Shan Shi Xin Ning Pharmaceutical Co., Ltd. romanized | Y20190008432 | A | Exact ingredient | 2026/04/03 | CDE |
| 氯化钾 · No verified English name | Xian Li Jun Jing Hua Pharma Co., Ltd. romanized | Y20190005465 | A | Exact ingredient | 2025/11/21 | CDE |
| 氯化钾 · No verified English name | Yunnan Da Tang Han Fang Pharmaceutical Co., Ltd. romanized | Y20190005363 | A | Exact ingredient | — | CDE |
| 氯化钾 · No verified English name | Jilin Sheng Xi Dian Pharma Technology Development Co., Ltd. romanized | Y20190003452 | A | Exact ingredient | 2025/09/18 | CDE |
| 氯化钾 · No verified English name | Beijing Shi Yan Jing Pharma Co., Ltd. romanized | Y20190002514 | A | Exact ingredient | 2026/02/04 | CDE |
| 氯化钾 · No verified English name | Chongqing Xin Da Xin Pharma Co., Ltd. romanized | Y20190001967 | A | Exact ingredient | 2026/05/20 | CDE |
| 氯化钾 · No verified English name | Zi Gong Hong He Pharmaceutical Co., Ltd. romanized | Y20180000646 | A | Exact ingredient | 2019/01/18 | CDE |
| 氯化钾 · No verified English name | Dead Sea Works Ltd. | Y20180001476 | A | Exact ingredient | 2026/04/21 | CDE |
| 氯化钾 · No verified English name | Tianjin Hai Guang Pharma Co., Ltd. romanized | Y20180000599 | I | Exact ingredient | 2018/12/17 | CDE |
| 氯化钾 · No verified English name | Jiangsu Sheng Qin Fen Pharma Co., Ltd. romanized | Y20180000044 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
CYHS2500460 · 国药准字H20266302
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 25 ↗CYHS2500457 · 国药准字H20266301
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 24 ↗CYHS2602172
Fact date: 2026/09/01 · Site observation date: 2026/10/22
View source ↗CYHB2601567
Fact date: 2026/08/18 · Site observation date: 2026/10/21
View source ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy